DOCTEUR YVAN CALOZET
ActiveDOCTEUR YVAN CALOZET has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €253k and a net result of €40k. Equity is growing by ~6.5% per year across the filed fiscal years. Its solvency ranks better than 49% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
86
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▼-6
Solvency87▼-6
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
Liquidity ample (current ratio 2.31 against 2.48 in 2024; short-term debt: 36.7% and cash: 31% of total assets), and 38.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
61.7%
Return on assets
9.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-08-2026, 3 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
3 d late
2024
11 d late
2023
5 d late
2022
10 d late
2021
9 d late
2020
2 d late
2019
2 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€253k▲ 1.7%
2024 · €249k
2018: €141k
2019: €180k
2020: €199k
2021: €181k
2022: €216k
2023: €196k
2024: €249k
2018 → 2025
Total assets
€411k▲ 11.4%
2024 · €369k
2018: €302k
2019: €316k
2020: €332k
2021: €375k
2022: €342k
2023: €321k
2024: €369k
2018 → 2025
Net result
€40k▼ 23.9%
2024 · €53k
2018: €14k
2019: €39k
2020: €19k
2021: €51k
2022: €35k
2023: €31k
2024: €53k
2018 → 2025
Working capital
€198k▲ 15.6%
2024 · €171k
2018: €40k
2019: €82k
2020: €111k
2021: €99k
2022: €146k
2023: €121k
2024: €171k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€181k-€216k▲ 19.6%€196k▼ 9.0%€249k▲ 26.9%€253k▲ 1.7%
Operating result€78k-€57k▼ 26.3%€48k▼ 15.9%€73k▲ 51.5%€58k▼ 21.1%
Net result€51k-€35k▼ 30.3%€31k▼ 12.4%€53k▲ 70.3%€40k▼ 23.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 21% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €411k
Fixed assets
€63k▼ 24.3%
Current assets
€348k▲ 21.8%
Equity and liabilities €411k
Equity
€253k▲ 1.7%
Debt
€158k▲ 31.8%
The debt ratio rises from 32.4% to 38.3%. Equity and debt are higher.
Key figures and ratios
EBITDA
€67k▼
2024 · €85k
Cash flow
€50k▼
2024 · €65k
Solvency
61.7%▼
2024 · 67.6%
Current ratio
2.31▼
2024 · 2.48
Quick ratio
2.31▼
2024 · 2.48
Debt / equity
0.62▲
2024 · 0.48
ROE
15.9%▼
2024 · 21.2%
ROA
9.8%▼
2024 · 14.3%
Interest coverage
9.47▼
2024 · 14.74
Debt
€158k▲
2024 · €120k
Debt ≤ 1 year
€151k▲
2024 · €115k
Income taxes
€16k▼
2024 · €20k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€369k€411k▲
Fixed assets21/28€83k€63k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€83k€63k▼
Land and buildings22€43k€39k▼
Plant, machinery and equipment23€26k€22k▼
Furniture and vehicles24€14k€2k▼
Current assets29/58€286k€348k▲
Amounts receivable within one year40/41€11k€10k▼
Trade receivables40€10k€8k▼
Other amounts receivable41€1k€2k▲
Current investments50/53€160k€210k▲
Cash at bank and in hand54/58€114k€127k▲
Deferred charges and accrued income490/1€675€594▼
Equity and liabilities
Total equity and liabilities10/49€369k€411k▲
Equity10/15€249k€253k▲
Contributions10/11€12k€12k=
Reserves13€235k€239k▲
Tax-exempt reserves132€3k€3k=
Distributable reserves133€233k€237k▲
Profit (loss) carried forward14€2k€2k▲
Amounts payable17/49€120k€158k▲
Amounts payable within one year42/48€115k€151k▲
Financial debts43€5k€4k▼
Credit institutions430/8€5k€4k▼
Trade debts44€780€2k▲
Suppliers440/4€780€2k▲
Taxes, remuneration and social security45€14k€13k▼
Taxes450/3€9k€8k▼
Remuneration and social security454/9€5k€5k=
Other amounts payable47/48€95k€132k▲
Accrued charges and deferred income492/3€4k€7k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€10k▼
Other operating charges640/8€1k€1k▼
Gross operating margin9900€86k€68k▼
Operating profit (loss)9901€73k€58k▼
Financial income75/76B€6k€6k▼
Recurring financial income75€6k€6k▼
Financial charges65/66B€6k€7k▲
Recurring financial charges65€6k€7k▲
Profit (loss) for the period before taxes9903€73k€56k▼
Income taxes67/77€20k€16k▼
Profit (loss) for the period9904€53k€40k▼
Profit (loss) for the period to be appropriated9905€53k€40k▼
Appropriation of the result
Profit (loss) to be appropriated9906€54k€42k▼
Profit (loss) brought forward from the previous period14P€1k€2k▲
Transfer from equity791/2-€36k
Transfer to equity691/2€53k€40k▼
To the legal reserve6920€53k€0▼
To other reserves6921-€40k
Profit to be distributed694/7-€36k
Return on contributions (dividend)694-€36k
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 3 days late
2025
11-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 11 days late
2024
31-12
Financial
Highest result since 2018net €53k ▲70.3%
Net result €53k, the highest in the series.
31-12
Financial
Equity above €200kEq €249k ▲26.9%
7 profitable years in a row build equity to €249k.
05-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 5 days late
2023
10-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 10 days late
2022
31-12
Financial
Equity above €200kEq €216k ▲19.6%
5 profitable years in a row build equity to €216k.
09-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 9 days late
2021
02-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 2 days late
2020
29-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Equity above €150kEq €180k ▲27.5%
2 profitable years in a row build equity to €180k.
05-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 5 days late
2018
16-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 16 days late
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herbeumont
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Le Quartier-du-Furgy, St-Médard 166887 HerbeumontGround area
868 m²
Building footprint
230 m²
Volume, LiDAR
1,223 m³
Parcel 84060A0698/00C000, Wallonia · tallest building 7.0 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 84060A0698/00C000 | Wallonia | 868 m² | 1 · 230 m² | 7.0 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
967600EIQ4PCG225NG67
Similar companies · same sector, comparable size
SYNLAB Flanders
BE 0780.553.951
Sint-Agatha-Berchem · Eq €254k
Dr. Veys Marie-Charlotte
BE 0719.823.736
Herent · Eq €255k
Dokter Daenen en Martens, huisartsen
BE 0536.798.097
Tongeren-Borgloon · Eq €256k
CENTRE RX DE WAVRE
BE 0450.606.867
Wavre · Eq €248k
AVEO Radiologie
BE 0737.777.545
Oud-Turnhout · Eq €248k
Of 698 companies in sector 86910 we hold annual accounts for 520. 412 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded01-08-2002
Fiscal year end31-12
Activities, NACEBEL
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.